|
|
|
Calbindin expression
(Journal Article): Bone and mineral metabolism in BB rats with long-term diabetes.
Verhaeghe J, Van Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, Faierman E, Bouillon R
IN:
Diabetes
1990; 39:477-482
Impact Factor(s) of Diabetes: 8.848 (2004), 8.298 (2003), 8.256 (2002), 7.7 (2001)
ABSTRACT:
The effect of long-term diabetes mellitus on bone and mineral metabolism was studied in BB rats. Diabetic rats were treated with 1 U of long-acting insulin every other day for 12 w...
Click HERE for details
(Journal Article): Plasma membrane calcium pump and 28-kDa calcium binding protein in cells of rat kidney distal tubules.
Borke JL, Caride A, Verma AK, Penniston JT, Kumar R
IN:
Am J Physiol
1989; 257:F842-F849
ABSTRACT:
In an effort to extend our studies on Ca2+ pumps to animal models, we developed a new monoclonal antibody (5F10) prepared against the human erythrocyte Ca2+-Mg2+-adenosinetriphosph...
Click HERE for details
(Journal Article): Localization of the epithelial Ca(2+) channel in rabbit kidney and intestine.
Hoenderop JG, Hartog A, Stuiver M, Doucet A, Willems PH, Bindels RJ
IN:
J Am Soc Nephrol
2000; 11:1171-1178
Impact Factor(s) of J Am Soc Nephrol: 6.644 (2004), 7.499 (2003), 6.337 (2001)
ABSTRACT:
The epithelial Ca(2+) channel (ECaC), which is exclusively expressed in 1,25-dihydroxyvitamin D(3)-responsive tissues, i.e., kidney, intestine, and placenta, is postulated to const...
Click HERE for details
(Journal Article): The cyclosporine A-induced decrease in rat renal calbindin-D28kDa protein as a consequence of a decrease in its mRNA.
Grenet O, Varela MC, Staedtler F, Steiner S
IN:
Biochem Pharmacol
1998; 55(7):1131-1133
Impact Factor(s) of Biochem Pharmacol: 3.436 (2004), 2.993 (2003), 3.542 (2002), 3.34 (2001)
ABSTRACT:
Cyclosporine A (CsA) is a potent immunosuppressant with the drawback of renal side-effects. We recently reported that relatively high doses of CsA markedly decreased the calcium-bi...
Click HERE for details
(Journal Article): Decrease in kidney calbindin-D 28kDa as a possible mechanism mediating cyclosporine A- and FK-506-induced calciuria and tubular mineralization.
Aicher L, Meier G, Norcross AJ, Jakubowski J, Varela MC, Cordier A, Steiner S
IN:
Biochem Pharmacol
1997; 53(5):723-731
Impact Factor(s) of Biochem Pharmacol: 3.436 (2004), 2.993 (2003), 3.542 (2002), 3.34 (2001)
ABSTRACT:
The use of the immunosuppressant cyclosporine A (CsA) is limited by its adverse renal effects. Most recently, we reported that the drug markedly decreases the levels of the calcium...
Click HERE for details
(Journal Article): Cytoprotective effects of calbindin-D(28k) against antimycin-A induced hypoxic injury in proximal tubular cells.
Wu MJ, Lai LW, Lien YH
IN:
Life Sci
2002; 71(5):559-569
Impact Factor(s) of Life Sci: 2.158 (2004), 1.944 (2003), 1.824 (2002), 1.758 (2001)
ABSTRACT:
Intracellular calcium plays an important role on the pathogenesis of hypoxia-induced cellular injury. Calbindin-D(28k), a cytosolic vitamin D-dependent calcium binding protein, can...
Click HERE for details
(Journal Article): Altered calbindin mRNA expression and calcium regulating hormones in rat diabetic pregnancy.
Hamilton K, Tein M, Glazier J, Mawer EB, Berry JL, Balment RJ, Boyd RD, Garland HO, Sibley CP
IN:
J Endocrinol
2000; 164(1):67-76
Impact Factor(s) of J Endocrinol: 3.319 (2004), 3.023 (2003), 2.834 (2001)
ABSTRACT:
Offspring of rats with diabetes mellitus are at risk of reduced calcium and bone mineral content. Altered expression of the maternal calcium binding proteins, calbindin-D(9K) and c...
Click HERE for details
|
| Contribute
to this subject area!
|
|
|
|
|
